Nexviazyme Injection, Powder, Lyophilized, For Solution
Product Images NDC 58468-0426

3 FDA label images from Genzyme Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nexviazyme (NDC 58468-0426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Nexviazyme 01)

Figure 1 (Nexviazyme 01)
A line graph comparing the least squares mean change in forced vital capacity (FVC) percent predicted over 49 weeks between Nexviazyme (avalglucosidase alfa-ngpt) and alglucosidase alfa. Nexviazyme shows a higher increase (+2.89%) compared to alglucosidase alfa (+0.46%). Patient numbers at baseline and each timepoint are listed below the graph for both treatments.*
FDA Label Image

Figure 2 (Nexviazyme 02)

Figure 2 (Nexviazyme 02)
A line graph comparing the LS mean change in 6MWT (6-minute walk test) distance over time for Nexviazyme and Alglucosidase alfa. The x-axis shows time points from Baseline to Week 49, and the y-axis shows change in 6MWT distance in meters. Nexviazyme shows a steady increase up to +32.21 meters, while Alglucosidase alfa shows smaller changes, ending near +2.19 meters. Patient numbers at each time point are noted below the graph for both treatments.*
FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Principal Display Panel (100 mg Vial Carton)
Nexviazyme 100 mg per vial injection powder lyophilized for solution carton label. Avalglucosidase alfa-ngpt for intravenous infusion after reconstitution and dilution. Label shows product name, strength, route, single-dose vial instructions, storage conditions to keep refrigerated at 2°C to 8°C, manufacturer Genzyme Corporation, origin Belgium, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.